Source: Eur Respir J 2011; 38: 1425-1430
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Hirata T., Yonemori K., Hirakawa A., Shimizu C., Tamura K., Ando M., Katsumata N., Tanimoto M., Fujiwara Y.. Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients. Eur Respir J 2011; 38: 1425-1430

Member's Comments

No comment yet.

Related content which might interest you: Systemic treatment of malignant pleural effusion Source: Annual Congress 2005 - What's new in the pleura Year: 2005 Talc chemotherapeutic pleurodesis to palliate malignant pleural effusions secondary to breast cancer Source: Eur Respir J 2003; 22: Suppl. 45, 509s Year: 2003 Efficacy of EGFR-TKI for malignant pleural effusion in lung adenocarcinoma patients Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Survival of lung adenocarcinoma patients with malignant pleural effusion Source: Eur Respir J 2013; 41: 1409-1418 Year: 2013 Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions Source: Eur Respir J 2004; 24: 263-266 Year: 2004 Thoracoscopy in malignant pleural effusions secondary to breast cancer Source: Eur Respir J 2006; 28: Suppl. 50, 611s Year: 2006 An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis Year: 2006 Is there any advantage of chemotherapy on survival of patients with diffuse malignant pleural mesothelioma? Source: Eur Respir J 2003; 22: Suppl. 45, 29s Year: 2003 Pleural effusion in lung cancer and targeted therapy Source: Hands-on Course 2013 - Medical Thoracoscopy Year: 2013 Management of malignant pleural effusion in recurrent SCLC by intrapleural gene therapy Source: Eur Respir J 2003; 22: Suppl. 45, 61s Year: 2003 Clinical and biological prognostic factors in malignant pleural effusion (MPE) secondary to breast cancer Source: Annual Congress 2005 - What's new in the pleura Year: 2005 Videothoracoscopy in the treatment of malignant pleural effusions Source: Annual Congress 2009 - Pleural and mediastinal diseases Year: 2009 Malignant pleural disease in primary lung cancer Source: Eur Respir Mon; 2009: 44: 318–335 Year: 2009 Chemotherapy for treatment of malignant pleural mesothelioma Source: Eur Respir J 2004; 24: Suppl. 48, 526s Year: 2004 Bevacizumab-targeted therapy for malignant pleural mesothelioma Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs Year: 2017 Predictors of survival in patients with recurrent malignant pleural effusion Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases Year: 2008 Malignant pericardial effusion in lung cancer patients Source: Annual Congress 2006 - Treatment and complications of treatment of lung cancer and malignant pleural effusions Year: 2006 Predictors of successful pleurodesis for patients with malignant pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 493s Year: 2004 Talc pleurodesis in malignant pleural effusions: A 5-year experience Source: Annual Congress 2012 - Medical access to the pleura Year: 2012 Evaluation of concomitant pleural effusions in patients with lung cancers Source: Eur Respir J 2007; 30: Suppl. 51, 668s Year: 2007